Market revenue in 2023 | USD 55,735.6 million |
Market revenue in 2030 | USD 75,231.5 million |
Growth rate | 4.4% (CAGR from 2023 to 2030) |
Largest segment | Clinical chemistry |
Fastest growing segment | Medical Microbiology & Cytology |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Human & Tumor Genetics, Clinical Chemistry, Medical Microbiology & Cytology, Other Esoteric Tests |
Key market players worldwide | Labcorp Holdings Inc, Qiagen NV, Eurofins Scientific SE, Quest Diagnostics Inc, OPKO Health Inc, Siemens Healthineers AG ADR, NeoGenomics Inc, Fresenius Medical Care AG, Sonic Healthcare Ltd, Charles River Laboratories International Inc, SYNLAB Group, Mayo Clinic |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical laboratory service market will help companies and investors design strategic landscapes.
Clinical chemistry was the largest segment with a revenue share of 62.78% in 2023. Horizon Databook has segmented the Asia Pacific clinical laboratory service market based on human & tumor genetics, clinical chemistry, medical microbiology & cytology, other esoteric tests covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific is expected to witness the fastest growth over the forecast period. Presence of unmet medical needs, positive economic growth and increasing scientific research, are some of the primary growth drivers of this market.
Additionally, an improved healthcare regulatory environment in high growth nations is anticipated to draw in foreign investors and encourage them to take advantage of the chances that are presented. Positive developments like government healthcare benefits, raised public knowledge, and a willingness to pay for top-notch medical care are also anticipated to fuel market expansion.
The region comprises over one-third of the global population. China and India are considered prospective business hubs for clinical testing & service providers. Furthermore, with increase in disposable income, urbanization, education, and awareness about prevention of severe diseases, the market is expected to grow in this region.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific clinical laboratory service market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific clinical laboratory service market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account